CNCR vs. HRTS ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Tema Cardiovascular and Metabolic ETF (HRTS)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.47

Average Daily Volume

3,758

Number of Holdings *

67

* may have additional holdings in another (foreign) market
HRTS

Tema Cardiovascular and Metabolic ETF

HRTS Description Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$30.26

Average Daily Volume

15,012

Number of Holdings *

36

* may have additional holdings in another (foreign) market
Performance
Period CNCR HRTS
30 Days -12.86% -11.84%
60 Days -15.35% -14.01%
90 Days -9.61% -12.42%
12 Months 25.35%
1 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in HRTS Overlap
REGN F 0.92% 2.38% 0.92%
CNCR Overweight 66 Positions Relative to HRTS
Symbol Grade Weight
GLUE C 2.1%
RAPT F 1.96%
RVMD B 1.73%
ACLX C 1.71%
EXEL B 1.69%
CRBU D 1.69%
MRSN C 1.67%
ELVN C 1.65%
MGNX D 1.62%
DAWN D 1.54%
SNDX F 1.53%
REPL C 1.52%
YMAB F 1.52%
STRO D 1.51%
BPMC C 1.49%
GNLX D 1.47%
KPTI D 1.46%
ALLO D 1.43%
XNCR B 1.43%
ERAS C 1.42%
MRUS D 1.39%
HCM F 1.39%
AURA C 1.39%
IOVA D 1.38%
ARVN D 1.38%
JANX C 1.38%
RPTX D 1.38%
BMY B 1.38%
NRIX C 1.37%
ZNTL D 1.37%
RXRX F 1.36%
RCUS F 1.35%
KYMR C 1.34%
IMCR F 1.34%
ACRV D 1.33%
BMEA F 1.31%
FHTX C 1.29%
BCYC F 1.28%
TSVT F 1.26%
LYEL F 1.26%
PGEN F 1.25%
GERN F 1.24%
SWTX C 1.22%
SDGR D 1.21%
CGEM F 1.21%
VOR D 1.21%
NUVB C 1.2%
AUTL F 1.19%
BNTX D 1.14%
ACET F 1.12%
GMAB F 1.11%
MRK F 1.11%
NUVL D 1.09%
KURA F 1.08%
IDYA F 1.08%
IPHA F 1.07%
IGMS F 1.05%
TYRA F 1.02%
LEGN F 1.0%
RLAY F 0.98%
ITOS F 0.98%
SMMT D 0.93%
IMTX F 0.93%
IMRX F 0.85%
FATE F 0.78%
PRLD F 0.58%
CNCR Underweight 35 Positions Relative to HRTS
Symbol Grade Weight
AMGN F -7.97%
VRTX C -5.7%
ALNY D -5.04%
LLY F -4.94%
BBIO F -3.93%
CRNX C -3.86%
CYTK D -3.48%
BSX A -2.85%
MDT D -2.7%
MREO F -2.63%
IONS F -2.41%
MASI B -2.29%
DXCM C -2.28%
ASND F -2.25%
KROS D -2.24%
MIRM C -2.23%
MLYS D -2.06%
RCKT F -2.01%
PODD A -1.83%
EW C -1.81%
NTLA F -1.74%
ARWR D -1.71%
RARE F -1.71%
MDGL C -1.6%
AKRO C -1.4%
WST C -1.3%
NVS D -1.22%
SLN F -1.08%
EWTX C -1.01%
NARI B -0.96%
VKTX F -0.82%
TERN F -0.74%
VERV F -0.71%
TNYA D -0.56%
RANI D -0.3%
Compare ETFs